Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: A systematic review and economic evaluation

J. Hislop (Lead / Corresponding author), Z. Quayyum, A. Elders, C. Fraser, D. Jenkinson, G. Mowatt, P. Sharma, L. Vale, R. Petty

Research output: Contribution to journalReview articlepeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: A systematic review and economic evaluation'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences